Michael Lock

1.9k citations

37 papers · 1.4k indexed · 2 hit papers · h-index 17

Impact in

Endocrinology top 2%
- Vibrio bacteria research studies
- Escherichia coli research studies
Psychiatry and Mental health top 2%
- Epilepsy research and treatment

Papers in ⓘ

Endocrinology 11
- Vibrio bacteria research studies 11
- Escherichia coli research studies 6
Psychiatry and Mental health 12
- Epilepsy research and treatment 12

Co-authors: Marc Gurwith (11 shared papers)Anupam Agarwal (9 shared papers)Bradley S. Galer (12 shared papers)Gail Farfel (11 shared papers)Kelly G. Knupp (8 shared papers)Arnold R. Gammaitoni (10 shared papers)Lieven Lagae (10 shared papers)Glenn Morrison (6 shared papers)
Journals: Vaccine (5 papers)Epilepsia (4 papers)Clinical and Vaccine Immunology (3 papers)American Journal of Tropical Medicine and Hygiene (3 papers)Neurology (2 papers)
Partner nations: United States Belgium France

In The Last Decade

Michael Lock

37 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial 2019 · 249 citations

Peers

Countries citing papers authored by Michael Lock

Since Specialization

Citations

This map shows the geographic impact of Michael Lock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lock more than expected).

Fields of papers citing papers by Michael Lock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lock. The network helps show where Michael Lock may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Lock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Lock Line = papers co-authored together Michael Lock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial The Lancet ·Lieven Lagae, Joseph Sullivan, Kelly G. Knupp, Linda Laux, Tilman Polster, Marina Nikanorova, Orrin Devinsky, J. Helen Cross, Renzo Guerrini, Dinesh Talwar, Ian Miller, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Arun Mistry, Glenn Morrison, Michael Lock, Anupam Agarwal, Wyman W. Lai, Berten Ceulemans Hit paper breakdown →	2019	249
2	Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens JAMA Neurology ·Rima Nabbout, Arun Mistry, Sameer M. Zuberi, Nathalie Villeneuve, António Gil‐Nagel, Rocío Sánchez‐Carpintero, Ulrich Stephani, Linda Laux, Elaine Wirrell, Kelly G. Knupp, Catherine Chiron, Gail Farfel, Bradley S. Galer, Glenn Morrison, Michael Lock, Anupam Agarwal, Stéphane Auvin, (unknown) Hit paper breakdown →	2019	180
3	Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor Clinical Infectious Diseases ·Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick, Rebecca C. Brady, David Galloway, Marc Gurwith, R. H. Hall, Robert A. Kessler, Michael Lock, Douglas J. Haney, Caroline E. Lyon, Marcela F. Pasetti, Jakub K. Simon, Flóra Szabó, Sharon M. Tennant, Myron M. Levine	2016	128
4	Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study The Lancet Infectious Diseases ·Marc Gurwith, Michael Lock, Eve M. Taylor, Glenn Ishioka, Jeff Alexander, Tim Mayall, John Ervin, Richard N. Greenberg, Cynthia Strout, John J. Treanor, Richard J. Webby, Peter F. Wright	2013	122
5	Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial Vaccine ·Geoffrey J. Gorse, W Keitel, Harry Keyserling, D TAYLOR, Michael Lock, Kristen Alves, Julie Kenner, Lynne Deans, Marc Gurwith	2006	83
6	Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome JAMA Neurology ·Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Svetlana Shore, Anupam Agarwal, Michael Lock, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Ronald L. Davis, António Gil‐Nagel	2022	82
7	Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome Seizure ·J. Helen Cross, Bradley S. Galer, António Gil‐Nagel, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, An‐Sofie Schoonjans, Elizabeth Donner, Elaine Wirrell, Sanjeev V. Kothare, Anupam Agarwal, Michael Lock, Arnold R. Gammaitoni	2021	61
8	Fenfluramine HCl (Fintepla^®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study Epilepsia ·Joseph Sullivan, Ingrid E. Scheffer, Lieven Lagae, Rima Nabbout, Milka Pringsheim, Dinesh Talwar, Tilman Polster, Bradley S. Galer, Michael Lock, Anupam Agarwal, Arnold R. Gammaitoni, Glenn Morrison, Gail Farfel	2020	57
9	PaxVax CVD 103-HgR single-dose live oral cholera vaccine Expert Review of Vaccines ·Myron M. Levine, Wilbur H. Chen, James B. Kaper, Michael Lock, Lisa Danzig, Marc Gurwith	2017	47
10	Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge Vaccine ·Cyril Empig, Julie Kenner, Marcel Perret-Gentil, Bryan Youree, Edward F. Bell, Allen Chen, Marc Gurwith, Keith Higgins, Michael Lock, Amanda D. Rice	2005	46
11	Model-Free Curve Estimation. Biometrics ·M. C. Jones, Michael E. Tarter, Michael Lock	1994	44
12	Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks Clinical and Vaccine Immunology ·Wilbur H. Chen, Richard N. Greenberg, Marcela F. Pasetti, Sofie Livio, Michael Lock, Marc Gurwith, Myron M. Levine	2013	40
13	Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study Epilepsia ·Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Shikha Polega, Ronald L. Davis, António Gil‐Nagel	2022	36
14	Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial Epilepsia ·Joseph Sullivan, Lieven Lagae, J. Helen Cross, Orrin Devinsky, Renzo Guerrini, Kelly G. Knupp, Linda Laux, Marina Nikanorova, Tilman Polster, Dinesh Talwar, Berten Ceulemans, Rima Nabbout, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Michael Lock, Anupam Agarwal, Ingrid E. Scheffer, (unknown)	2023	31
15	Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients Are Responsive to Methotrexate, Anti-TNF, and T Cell Costimulatory Modulation Inflammation ·Manish Jain, Mukundan Attur, Vika Furer, John A. Todd, R. Flores Ramírez, Michael Lock, Quynh Anh Lu, Steven B. Abramson, Jeffrey D. Greenberg	2014	26
16	Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population Clinical and Vaccine Immunology ·Douglas J. Haney, Michael Lock, Jakub K. Simon, Jason B. Harris, Marc Gurwith	2017	24
17	Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection Vaccine ·Douglas J. Haney, Michael Lock, Marc Gurwith, Jakub K. Simon, Glenn Ishioka, Mitchell B. Cohen, Beth D. Kirkpatrick, Caroline E. Lyon, Wilbur H. Chen, Marcelo B. Sztein, Myron M. Levine, Jason B. Harris	2018	20
18	Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18–45 Vaccine ·James McCarty, Michael Lock, Kristin M. Hunt, Jakub K. Simon, Marc Gurwith	2018	14
19	Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth Epilepsy & Behavior ·António Gil‐Nagel, Joseph Sullivan, Berten Ceulemans, Elaine Wirrell, Orrin Devinsky, Rima Nabbout, Kelly G. Knupp, Μ. Scott Perry, Tilman Polster, Ronald L. Davis, Michael Lock, Robert M. Cortes, Arnold R. Gammaiton, Gail Farfel, Bradley S. Galer, Anupam Agarwal	2021	14
20	High Incidence of Unusual Cysteine Variants in gp120 Envelope Proteins from Early HIV Type 1 Infections from a Phase 3 Vaccine Efficacy Trial AIDS Research and Human Retroviruses ·David V. Jobes, Melissa Daoust, Vivian Nguyen, Allan Padua, Suzanne M. Michele, Michael Lock, Allen Chen, Faruk Sinangil, Phillip W. Berman	2006	13

About Michael Lock

Michael Lock is a scholar working on Endocrinology, Psychiatry and Mental health, Virology, Pediatrics, Perinatology and Child Health and Modeling and Simulation, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epilepsy research and treatment (12 papers), Vibrio bacteria research studies (11 papers), Influenza Virus Research Studies (9 papers), Pharmacological Effects and Toxicity Studies (8 papers), Escherichia coli research studies (6 papers), Neonatal and fetal brain pathology (4 papers), Poxvirus research and outbreaks (2 papers) and Atomic and Subatomic Physics Research (2 papers). The work is most often cited by research in Endocrinology (237 citations), Psychiatry and Mental health (628 citations), Pediatrics, Perinatology and Child Health (417 citations), Virology (92 citations) and Cellular and Molecular Neuroscience (286 citations). Michael Lock has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Marc Gurwith, Anupam Agarwal, Bradley S. Galer, Gail Farfel, Kelly G. Knupp, Arnold R. Gammaitoni, Lieven Lagae, Glenn Morrison, Joseph Sullivan and Berten Ceulemans. Their work appears in journals such as Vaccine, Epilepsia, Clinical and Vaccine Immunology, American Journal of Tropical Medicine and Hygiene and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact